- Ann Tucker
SAMHSA Warns of Growing Threat from Xylazine
SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
DEA [3/22] | In a public safety alert, the DEA said it observed a sharp increase in the trafficking of fentanyl mixed with xylazine, a sedative also known as “Tranq” that has been approved by the Food
U.S. Senate [3/28] | Several senators are introducing the Combating Illicit Xylazine Act, bipartisan, bicameral legislation to crack down on and schedule the highly dangerous sedative causing fatal ov